Alpha Tau Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRTS and other ETFs, options, and stocks.About DRTS
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer.
CEOUzi Sofer
CEOUzi Sofer
Employees112
Employees112
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2015
Founded2015
Employees112
Employees112
DRTS Key Statistics
Market cap430.58M
Market cap430.58M
Price-Earnings ratio-9.70
Price-Earnings ratio-9.70
Dividend yield—
Dividend yield—
Average volume376.49K
Average volume376.49K
High today$5.49
High today$5.49
Low today$4.23
Low today$4.23
Open price$4.54
Open price$4.54
Volume1.30M
Volume1.30M
52 Week high$5.49
52 Week high$5.49
52 Week low$2.30
52 Week low$2.30
Stock Snapshot
As of today, Alpha Tau Medical(DRTS) shares are valued at $5.20. The company's market cap stands at 430.58M, with a P/E ratio of -9.70.
On 2025-12-11, Alpha Tau Medical(DRTS) stock moved within a range of $4.23 to $5.49. With shares now at $5.20, the stock is trading +22.9% above its intraday low and -5.3% below the session's peak.
Trading activity shows a volume of 1.3M, compared to an average daily volume of 376.49K.
The stock's 52-week range extends from a low of $2.30 to a high of $5.49.
The stock's 52-week range extends from a low of $2.30 to a high of $5.49.
People also own
Based on the portfolios of people who own DRTS. This list is generated using Robinhood data, and it’s not a recommendation.